Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunction

Research output: Contribution to journalReview ArticleResearchpeer-review

27 Citations (Scopus)


Although intensive glycaemic and blood pressure control have reduced the risks of micro- and macrovascular complications, diabetes remains a major cause of cardiovascular events, end-stage renal failure, blindness and neuropathy. It is therefore imperative to understand the underlying mechanisms and to establish effective treatments to prevent, retard or reverse diabetic complications. One area of increased focus is the diabetic vascular endothelium. Hyperglycaemia triggers a cascade of events, not least an increase in reactive oxygen species (ROS) leading to enhanced oxidative stress, with its negative impact on endothelial function. In this review, we explore a unifying hypothesis that increased glucose-mediated ROS leads to endothelial dysfunction as the underpinning causative event triggering accelerated micro- and macrovascular complications. In particular, the consequences of deficiencies in the antioxidant enzyme, glutathione peroxidase, on endothelial dysfunction as a trigger of diabetic micro- and macrovascular complications, will be reviewed. Furthermore, novel antioxidant therapies will be highlighted. Specifically, use of Gpx1-mimetics holds promise as a targeted antioxidant approach and an alternative adjunct therapy to reduce diabetic complications.

Original languageEnglish
Pages (from-to)709-729
Number of pages21
JournalFrontiers in Bioscience-Scholar
Publication statusPublished - 1 Jan 2011
Externally publishedYes


  • Diabetic Complications
  • Ebselen
  • Endothelial Dysfunction
  • Glutathione Peroxidase
  • Macrovascular Disease
  • Microvascular Disease
  • Oxidative Stress
  • Review
  • Targeted Antioxidant Defences

Cite this